EUVIMEDEUVIMED entdecken
Crossref

PREVENTION OF DEVELOPMENT OF TYPE 2 DIABETES MELLITUS BY LOSARTAN IN COMPARISON WITH PIOGLITAZONE IN A RAT MODEL

MUHAMMAD NAUMAN SHAD, ZUJAJA ZAHEER, SADIA CHIRAGH

Pakistan Postgraduate Medical Journal · 2013

DOI: 10.51642/ppmj.v24i4.211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Postgraduate Medical Journal, 2013. Verfasst von MUHAMMAD NAUMAN SHAD und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to the increased incidence and prevalence of type 2 diabetes mellitus, there is increased need for the search of drugs that may be useful in preventing/delaying the onset of this disease.

Objective

To compare the preventive effects of losartan and pioglitazone on the development of type 2 diabetes mellitus in a rat model fed on a high fat diet.

Methods

Study was conducted on 45 Sprague-Dawley rats divided into three randomized groups. All the rats were fed a high fat diet meant for inducing type 2 diabetes. Pioglitazone or losartan was given to the rats in group B and C respectively. Fasting blood glucose levels and body weight were determined weekly. At the end of the 12 week study period, Serum Insulin and CRP (C-Reactive Protein) levels were also determined.

Results

Rats in groups B and C gained less weight and had lower fasting BSL than those in control group A. Results show that the mean serum insulin and CRP levels were significantly low in group B and C as compared to those in group A while difference between group B and C was statistically insignificant. The number of diabetic rats in group B and C was significantly lower as compared to group A at the end of study. Number of diabetic rats remained constant in pioglitazone treated rats after 10th week of study, while it kept on increasing in losartan treated group.

Conclusion

Pioglitazone delays and prevents development of type 2 diabetes while losartan only has a delaying effect.

Zitieren

APA

SHAD, M. N., ZAHEER, Z., & CHIRAGH, S. (2013). PREVENTION OF DEVELOPMENT OF TYPE 2 DIABETES MELLITUS BY LOSARTAN IN COMPARISON WITH PIOGLITAZONE IN A RAT MODEL. Pakistan Postgraduate Medical Journal. https://doi.org/10.51642/ppmj.v24i4.211

Vancouver

SHAD MN, ZAHEER Z, CHIRAGH S. PREVENTION OF DEVELOPMENT OF TYPE 2 DIABETES MELLITUS BY LOSARTAN IN COMPARISON WITH PIOGLITAZONE IN A RAT MODEL. Pakistan Postgraduate Medical Journal. 2013. doi:10.51642/ppmj.v24i4.211

BibTeX
@article{SHAD2013,
  author = {SHAD, MUHAMMAD NAUMAN and ZAHEER, ZUJAJA and CHIRAGH, SADIA},
  title = {PREVENTION OF DEVELOPMENT OF TYPE 2 DIABETES MELLITUS BY LOSARTAN IN COMPARISON WITH PIOGLITAZONE IN A RAT MODEL},
  journal = {Pakistan Postgraduate Medical Journal},
  year = {2013},
  doi = {10.51642/ppmj.v24i4.211}
}
Kostenlos starten →